Laserfiche WebLink
3. Drug take -back disposal or destruction programs. <br />4. Fund community anti -drug coalitions that engage in drug prevention efforts. <br />5. Support community coalitions in implementing evidence -informed prevention, such <br />as reduced social access and physical access, stigma reduction — including staffing, <br />educational campaigns, support for people in treatment or recovery, or training of <br />coalitions in evidence -informed implementation, including the Strategic Prevention <br />Framework developed by the U.S. Substance Abuse and Mental Health Services <br />Administration (SAMHSA). <br />6. Engage non -profits and faith -based communities as systems to support prevention. <br />7. Support evidence -informed school and community education programs and <br />campaigns for students. Families, school employees, school athletic programs, parent - <br />teacher and student associations, and others. <br />8. School -based or youth -focused programs or strategies that have demonstrated <br />effectiveness in preventing drug misuse and seem likely to be effective in preventing <br />the uptake and use of opioids. <br />9. Support community -based education or intervention services for families, youth, and <br />adolescents at risk for OUD and any co-occurring SUD/MH conditions, co -usage, <br />and/or co -addiction. <br />10. Support evidence -informed programs or curricula to address mental health needs of <br />young people who may be at risk of misusing opioids or other drugs, including <br />emotional modulation and resilience skills. <br />11. Support greater access to mental health services and supports for young people, <br />including services and supports provided by school nurses or other school staff, to <br />address mental health needs in young people that (when not properly addressed) <br />increase the risk of opioid or other drug misuse. <br />H. PREVENT OVERDOSE DEATHS AND OTHER HARMS <br />Support efforts to prevent or reduce overdose deaths or other opioid-related harms through <br />evidence -based, evidence -informed, or promising programs or strategies that may include, <br />but are not limited to, the following: <br />1. Increase availability and distribution of naloxone and other drugs that treat overdoses <br />for first responders, overdose patients, opioid users, families and friends of opioid <br />users, schools, community navigators and outreach workers, drug offenders upon <br />release from jail/prison, or other members of the general public. <br />2. Provision by public health entities of free naloxone to anyone in the community, <br />including but not limited to provision of intra-nasal naloxone in settings where other <br />options are not available or allowed. <br />3. Training and education regarding naloxone and other drugs that treat overdoses for <br />first responders, overdose patients, patients taking opioids, families, schools, and <br />other members of the general public. <br />4. Enable school nurses and other school staff to respond to opioid overdoses, and <br />provide them with naloxone, training, and support. <br />